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Background: Utilizing mouse models provides excellent immunological and experimental tools to study oral
immune responses. However for functional assays, isolating T lymphocytes from the oral tissues has proved to be
challenging due to the absence of reliable methods that yield viable cells with consistency. To study adaptive
immune cell interactions in the oral mucosal tissues, it is necessary to isolate T cells with a good viability and study
them at the single cell level.
Findings: We have established an improved method to isolate immune cells, including Tregs and Th17 cells from
intra-epithelial niches and lamina propria of the tongue, gingival and palatal tissues in the oral mucosa of mice.
Conclusion: This new method of isolating immune cells from oral tissues will enable us to further our understanding
of oral tissue immune cells and their role during oral infections and oral inflammation.
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Oral immunity and inflammation are associated with a
wide array of human health conditions including, but
not limited to, cancer, cardiovascular disease, graft ver-
sus host disease (GVHD), and infectious diseases such
as AIDS [1-5]. To study infections and inflammation,
murine models may be employed and are excellent tools
of immunology [6,7]. Cells such as T cells, dendritic cells,
and monocytes are major components of the adaptive im-
mune system and these types of cells have been studied
extensively in peripheral immune organs and mucosal tis-
sues, such as the gut and skin. Yet, these types of immune
cells that populate the oral mucosal tissues have been
studied much less and their precise functions in the oral
mucosa remain unclear. For example, studies have focu-
sed on T cells which are present in intra-epithelial com-
partments; i.e., oral lymphoid foci, and lamina propria
[8-10,17], and determined that these cells play significant
roles in oral immunity and inflammation [7,11,12]. The
majority of these studies have examined the oral tissues
using manual in situ immunohistochemistry or immuno-
fluorescence microscopy [9,10]. While these studies have
provided us basic information about these T cells, these
methods do not provide us with clear information* Correspondence: pxp226@case.edu
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unless otherwise stated.regarding their functions. Although T cells have been stud-
ied in oral tissues by flow cytometry [13], the cells isolated
using such crude methods frequently show poor viability.
It is difficult to study them in vitro, due to the scarcity and
inconsistent viability of these cells. Recently, a protocol
was published to detect T cells from the gingival tissues
[14], but not from the tongue and palatal tissues. Here we
describe a new, reproducible protocol to isolate > 94% vi-
able leukocytes from mouse oral palatal and tongue tissues.
The oral palatal, sublingual and tongue tissues are dis-
sected by incising the joint on both sides of the mouth,
opening the jaws and exposing the mouth [15]. The tissues
from two mice are collected in ice-cold phosphate buff-
ered saline (PBS) with antibiotics (penicillin (100 U/ml)
and streptomycin (100 U/ml). The tissue pieces are
flushed twice with PBS containing antibiotics; and are cut
into 3 mm× 3 mm pieces of tissues. The pieces are trans-
ferred to a 50 ml conical tube and rinsed 3 times with
2 ml of ice-cold RPMI-1640 containing antibiotics, 3%
fetal bovine serum (FBS) and 20 mM HEPES, followed by
decanting of the supernatant. The epithelium is disrupted
by adding 10 ml of RPMI-1640 containing antibiotics, 3%
FBS, 5 mM EDTA, 1 mM DTT and 20 mM HEPES to the
tissue pieces and incubating for 20 minutes at 37°C. The
pieces are allowed to sediment and the supernatant con-
taining epithelial cells and intra-epithelial lymphocytes is
strained through a 70 μm cell strainer into a fresh 50 mlal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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(Fraction-1). The epithelial cells and intra-epithelial lym-
phocytes within the sedimented tissues are further re-
moved by intense vortexing in 5 ml of RPMI-1640
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Figure 1 Viability, recovery and the expression of CD45, CD11c and C
(MOIL) isolated from the oral tissues of mice. Flow cytometric histogram
plots showing conventional leukocyte gating in our flow cytometry analyse
separation (bottom). (C) The percentage of viable cells (PI negative), as asse
mouse) from various strains of mice, as enumerated using hemocytometer
expression, which are the hematopoietic, monocytic, and dendritic cell ma
from 2 mice) are shown in the gates. All these data represent at least three
were calculated by Students ‘t’ test in Microsoft Excel software using two tThe supernatant is collected and strained using a 100 μm
strainer into another 50 ml tube and kept on ice (Frac-
tion-2). The process is repeated twice. Leaving the tissue
pieces behind, the supernatant is collected and strained
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D11b in mouse oral intra-epithelial and lamina propria leukocytes
s showing propidium iodide (PI) uptake by the dead cells (A), or dot
s (B), in crude cell preparations (top) and those isolated by percoll
ssed by flow cytometry as in (A). (D), MOIL cell recovery (cell count/1
. (E) Flow cytometric contour plots showing CD45.2, CD11b and CD11c
rkers, respectively. Percentages of marker expressing MOIL (pooled
to five independent experiments using at least 10- 15 mice. P values
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Figure 2 (See legend on next page.)
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Figure 2 Leukocyte and CD4 cell enrichment in MOIL isolated from the oral tissues using our method. (A) Flow cytometric dot plots
showing leukocyte gates (top), CD4 expression (middle) and CD25 and Foxp3 expression (bottom) in MOIL isolated by different methods (pooled from 10
mice) from different strains of mice (gated as shown). Mouse gut intra-epithelial and lamina propria leukocytes (MGIL) are shown as a control. (B) Flow
cytometric dot plots showing leukocyte gates (top) and CD4 expression (bottom) before (left) and after (right) the percoll centrifugation (C) Contour plots
showing CD45.2, CD3 and CD8 expression, which are the hematopoietic, T lymphocytic, and CD8+ T lymphocytic markers, respectively. Percentages of
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Figure 3 Specialized T cell subsets in MOIL isolated from the oral tissues of C57BL/6 mice. (A) Flow cytometric contour plots showing the
expression of various immune cell markers in MOIL cells CD3+ CD4+ RORγt + cells are shown as Th17 cells, CD3 + CD4 + CD25 + Foxp3+ cells are
shown as Tregs, CD11b- NK1.1- CD3- CD90.2+ CD45.2+ RORγt are shown as innate lymphoid cells (ILC). Percentages of marker expressing cells are
shown in the gates. These data are representative of two independent experiments using cells pooled from 10 mice. (B) Percentage of CD4 + Foxp3
(top) and CD4+ RORγt (bottom), in MOIL as assessed by flow cytometry from 5 independent experiments (as in Figure 2A). Spleen (SPLN), cervical
lymph nodes (CLN), mesenteric lymph nodes (MLN) and MGIL are used as controls. (C) Real time quantitative PCR analyses of mRNA levels of Foxp3,
RORγt and GAPDH (house keeping gene control) in cells isolated from SPLN, CLN and MOIL, with SPLN normalized to “1” to calculate the relative mRNA
levels. These data are representative of three independent experiments using 15 mice. P values were calculated by Ordinary one-way ANOVA test, with
multiple comparisons, using Prism 6.0 (GraphPad Software, Inc.).
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and epithelial cells and has to be further separated by gra-
dient centrifugation. The tissue pieces are rinsed 2-3 times
with 5 ml ice cold PBS to remove EDTA, decanting the
supernatant into the Fraction-2 tube. The sedimented
fragments are diced into smaller pieces and are added to
a 15 ml tube with 1 ml of RPMI-1640 with antibiotics,
collagenase-H (0.5 mg/ml), DNase (0.5 mg/ml) and
20 mM HEPES, and incubated at 37°C for 15 minutes
(Collagenase-H, SIGMA (34 Units/mg). After 15 minutes,
another 1 ml of collagenase buffer is added and incubated
for an additional 15 minutes. The resulting viscous solu-
tion is vortexed intensely and strained using a 70 μm
strainer into a 50 ml tube on ice (Fraction 3). 10 ml
of RPMI-1640 containing antibiotics, 3% FBS, DNase
(0.5 mg/mL) and 20 mM HEPES is added to the strainer
containing viscous material. At this point, there are almost
no visible pieces remaining in the tube. A syringe plungerDissecting out the oral tissues (to
gingival) fro
Tissue washing/pooling o
Gentle disruption of the epithelial la
 Tissue digestion using collagena
and DNase  
Filtering out the connective tissu
Percoll centrifugation to 
Vigorous disruption of the epithe
layer and connective tissue 
Pooling  three  fracti
MOEC float on the 30% 
Percoll layer 
Leukocytes, including i
propria immune cells (M
the 30% an
Figure 4 Flow chart of the major steps in the MOIL isolation method.is used to disrupt the pieces through the strainer, followed
by washing with the flow-through medium until the
strainer is clean. The flow-through is collected in the same
50 ml tube on ice (Fraction 3). Fractions -1, -2 and -3 are
centrifuged for 6 minutes at 1200 rpm, 4°C and then re-
suspended in 5 ml of PBS/EDTA. The fractions are pooled
and centrifuged for 10 min at 1200 rpm, 4°C.
To separate the leukocytes from the mouse oral epi-
thelial cells (MOEC), connective tissues, dead cells and
tissue clumps, the cells are resuspended in 4 ml of 30%
Percoll (made in PBS/EDTA) in a 15 ml tube. Using Pas-
teur pipettes, 5 ml of 70% Percoll (made in PBS/EDTA),
is carefully layered under the 4 ml cell suspension in a
15 ml tube. The tube is centrifuged for 15 min at
1100 × g, room temperature, with a low acceleration
rate. The fraction of cells enriched in epithelial cells float
on the 30% Percoll layer, while leukocytes, including
intra-epithelial and lamina propria immune cells arengue, palatal, sublingual and 
m mice  
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this population as mouse oral intra-epithelial and lamina
propria leukocytes (MOIL). Debris and dead cells will
pellet at the bottom of the conical tube. MOEC are re-
moved carefully and can be further purified if relevant.
MOIL are carefully collected, resuspended in complete
RPMI-1640 with 10% FBS in a 15 ml tube and washed
twice before use for cultures or immunofluorescence
staining.
Consistently, as shown by the viable stain propidium
iodide, the viability of the MOIL that we isolated was >
94% (propidium iodide negative) (Figure 1A, bottom,
1C). The crude method that just disrupts the tissue
using EDTA and enzymatic digestion, yields cells that
show inconsistent viability and recovery (Figure 1A, top,
1C). In Figure 1A, we used only the conventional
leukocyte gate in the forward scatter/side scatter dot
plot, as in all our analyses (unless otherwise specified)
(Figure 1B). We obtained ~ 0.8 × 106 – 1.2 × 106 MOIL
from the oral tissue of one mouse ex vivo from mouse
oral tissues, compared to 5 - 6 × 106 mouse gut intra-
epithelial and lamina propria leukocytes (MGIL), isolated
from the colon using a similar method (Figure 1D). In
this population of MOIL, we detected the presence of
CD45+ hematopoietic cells, CD11c + dendritic cells, and
CD11b + monocytes/macrophages (Figure 1E). Most im-
portantly, using our method, we could better enrich the
leukocytes (up to 80%) (Figure 2A, top), CD4+ T cells
(up to 13%) (Figure 2A, middle) compared to the crude
method, which much lower percentages of leukocytes.
We found that the frequency of CD4+ T cells is higher
in Balb/C mice than C57BL/6 mice in oral tissues
(Figure 2A, middle). Although the frequency of CD4
cells in MOIL (3- 13%) is not as high as in MGIL (10 -
30%), we could detect these cells and CD25 + Foxp3+
cells consistently (Figure 2A, bottom). The percoll centrifu-
gation especially enriches the leukocyte fraction (Figure 2B,
top) in general, and also the CD4+ cells (Figure 2B, bottom)
among the isolated MOIL. Moreover we could also detect
CD3+ CD45+ hematopoetic T cells that also included CD8+
T cells, (Figure 2C) and CD4+ cells as well (Figure 3A).
Among the CD3 +CD4+ cells, we found CD25 + Foxp3+
Tregs at a frequency of 6 - 17%, and CD44
high, ROR-γt +
Th17 cells up to a frequency of 40-60% in MOIL from
C57BL/6 mice (Figure 3A). We also detected the presence
of recently discovered CD90.2+ ROR-γt + CD3- NK1.1-
CD19- group 3 innate lymphoid cells (ILC) among MOIL
(Figure 3A). Flow cytometry data from at least 5 experi-
ments show that the frequency of CD4+CD25 + Foxp3+
Tregs is slightly higher in MOIL preparations, compared to
other tissue and lymphoid organs we examined (Figure 2A,
bottom, Figure 3B). Moreover, ROR-γt expressing CD4+
cells (Th17 cells) are significantly enriched in the MOIL
preparations compared to other tissue and lymphoid organs(Figure 3B). These data were also confirmed by real-time
quantitative PCR (Figure 3C). The cells isolated are ~95% vi-
able and can be further purified using cell sorting techniques
and cultured in vitro to study their precise functions [16].
The major steps of the protocol are outlined in a flow chart
(Figure 4).
This method will permit us to investigate the oral tis-
sue immune cells more carefully. We will employ this
method to study immune cell interactions with microbes
in infection models such as oropharyngeal candidiasis
(OPC) in mice. An important advantage of studying im-
mune mechanisms in the oral cavity at the cellular level
is that it will lead to novel ways of non-invasive mucosal
immunotherapy in easily accessible oral mucosal tissue,
compared to other sites such as gut and rectal mucosa.
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